Member Info for AJ316

You must have such a sad life to be posting utter garbage on the LSE discussion board on a bank holiday Monday, a day the market is closed.

I suggest you log off for a month and come back after actually seeing the data.

Up the rams

Stoped reading this 3 weeks ago because conversations with green boxes was doing my head in.. Come back today to see nothing has changed and people are still entertaining the madness.

I’ll try again in another 3 weeks.

PS - It has done me wonders not checking this multiple times a day after months and months of daily engagement and time wasted. I recommend others try it. Atleast untill news for your own sanity.

I think something which seems to not be given much thought or discussion anymore is the fact that a new strain could come along at any time. It doesn’t get spoken about much now because the scaremongering by the media seems to of all but gone. It is well known in the scientific community that the next variant could well be more severe.

This is a massive positive for synairgen. SNG001 will work against the next variant and any that follow, whereas others won’t just like we have seen with omicron. Do not underestimate the power in that detail.

This will be a massive part of EUA should they apply, they have a variant proof therapeutic, impeccable safety data all they need is the data to prove it works well enough to save lives. Should the deep dive and activ provide the latter I think it will breeze through EUA and be on shelves before the winter waves and any new variants take hold.

Big few months here we just need the data to be what we hope it to be.

Given the above I think it’s crazy it’s trading around 20p regardless of the failed end points on Sprinter and I’m gutted I don’t have funds to lower my average.

GLTA

Possible anytime in the next 8 weeks

It comes back to what we keep saying, coms has been poor but you can’t address investors with nothing to say. It would do more worse than good to just come out and false promise or over hype the data before they see it. If the presentation has many positives I expect a big increase in coms and things to move quickly in Q3, next month is make or break for 2022 in my opinion.

SNG001 will be used long after covid. Hold tight, hold long and you shall be rewarded. This therapeutic will get to market and it will save many life’s. Science doesn’t lie and neither does data.

The road hasn’t been easy and I’m sure the rest of the journey won’t either but with the data on safety and death reduction from 1 flawed trial, it’s clear to me with some fine tuning they will find a place on the world stage.

Anyone new here Ignore the de rampers and ignore the mardy babies who’s lost their family’s money and have gone bitter.

@J_CIT I can’t remember you posting utter boll*cks before P3 so I can only imagine you’ve gone bitter due to loosing a lot of money.. like the rest of us may I add.

To come out with there will be a placing around 15p just shows how stupid you clearly are.. they are trying to get on government funded platform trials, not start there own trials from scratch surely as an investor you’d know this ? Also if A2 P2 data was to land tomorrow and is good, and say first patient is dosed in a few weeks on P3 you really think this SP will be anywhere near the low 20’s then ?

You’ve just shown you’re not worth the time spend reading your posts in the future, done nothing but make yourself look foolish and dreams to new investors, green bin for you.

Wishful thinking but would be nice if this was the start of a slight upward trend heading into May, with more news and interviews to come over the next 60 days it is possible

Anti climax

I’d argue the fact they said activ P2 first half of the year to manage expectations and not aggregate investors with delays, should the results run up to June they are covered but I’d assume that’s worse case.

Both results are due in so it could be either. OR we can but dream they’ve got both and one hell of a master plan and are about to come back from the ashes!

I’m keeping my expectations low but hoping for some good news. We all deserve some after the start to this year we have had.

GLTA

For those who missed the tweet.. As always detective AIM doesn’t miss a trick. It clearly states Richard Marsden so is no mix up. Of the 50 the first one in the tittle of the tweet is Synairgen, very interesting.

https://twitter.com/aimdective/status/1511005773484154886?s=21&t=rpX4foc9157g-w5Y4bef1g

Coms has been poor but there has been a lot of progress made over the last two years a lot more than anyone on here is probably aware of. It’s not fair to **** off the management as much as some are. All will become apparent in time, the trial failed it’s end points I don’t think that’s all down to the management if I’m honest. **** happens, it was a complex trial and we was very close to meeting endpoints. Said it before and I’ll say it again let’s leave all the slander until we see the full data and next moves.

People saying things like RM will be gone and this won’t get anywhere with him moving forward are stupid.

I’ve always defended the management but my confidence is beginning to slide. The sheer lack of communication has been remarkable. No detailed update or conversation from any of the team from Synairgen to shareholders after an 85% slide in SP is not good. I believe they are waiting to come with a substantial update but some more communication would go along way. We have had a few carrots dangled in the update RNS but that is all.

So as you are on the comment page of this board, scroll to the top comment above there is a sub heading of ‘regular’ ‘premium’ or ‘filter’ these sit below the ‘share discussion for synairgen’ heading

Click the filter button and then you simply type the username of the individual you wish to filter. If your still struggling speak up and I’ll try to explain better. I’ve only ever filtered on iPhone through safari.

Bump
Use your filter

Simple step to make this board better, if you haven’t then filter the below, my board is constantly filed with people entertaining them. I look forward to when some normality returns here.

- Andybe4
- MrCosts
- Burstead
- Woodstock1970

I personally believe talk on what people will sell at shouldn’t be given much thought until a the full data is out and next steps are revealed.

If they have enough data from sprinter and A2 P2 to go for EUA then selling anywhere sub £2 is ridiculous because if it gets to market then this setback and current SP will soon be a thing of the past.

I’m holding till this gets to market whether that is 6 months or 2 years. If it fails then that’s my poor judgment but I believed the science 3 months ago just as I do now. I’m hoping the failed endpoints is just a minor setback in the grand scale of things.

GLTA genuine holders

Ignore the below it’s corrected itself

Live price won’t update from 12.13 on any platforms ?

I asked last night but got drowned out in green boxes.

What are peoples expectations in timeline for deep dive ?